J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez
{"title":"Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?","authors":"J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez","doi":"10.1016/j.rgmxen.2023.08.002","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"392-403"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia de Mexico (English)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rgmxen.2023.08.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.